1,505
Participants
Start Date
July 20, 2021
Primary Completion Date
August 5, 2021
Study Completion Date
August 6, 2021
Ticagrelor
Patients were survivors and treated with DAPT (aspirin \[100 mg once daily\], cilostazol, or indobufen)combined with a P2Y12 receptor antagonist \[clopidogrel (75 mg once daily) or ticagrelor (90 mg twice daily)\]) at the time of hospital discharge.All patients were followed for 1 year in the outpatient clinic after hospital discharge.
The First Affiliated Hospital of Dalian Medical University, Dalian
The First Affiliated Hospital of Dalian Medical University
OTHER